[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 16, Issue 4 (Winter 2006) ::
MEDICAL SCIENCES 2006, 16(4): 225-230 Back to browse issues page
Surveying Desferal production increment by inducing mutation in Streptomyces griseoflavus
Azim Akbarzadeh 1, Dariyoush Noruzian , Ali Farhangi , MOhammadreza Mehrabi , Seyedmohammad Atyabi , Davoud Zare , Karim Ammarzadeh , Hadi Ansari Hadipour , Mehri Mortazavi , Zahra Saffari , Morevarid Shafiee , Mrayam Mardaneh
1- , azimakbarzadeh@pasteur.ac.ir
Abstract:   (22028 Views)
Background: Desferal or Desferrioxamine B mesylate is an iron chealator drug. This medicine decreases the iron overload in the thalassemia patients who have been blood transfused the excess of iron is excreted through bile or urine. Novartis is the sole company which produces desferrioxamine B mesylate in the world and our country is importer of such drug. Thus we tried to increase Desferal production by inducing mutation in Streptomyces griseoflavus.
Materials and methods: This is an applied research carried out at pilot level. The organism is a Gram-positive bacterium that was supplied in lyophilized by Persian Type culture Collection, Iranian Research Organization for Science and Technology (IROST) ,Tehran, Iran bearing the code no. PTCC1130, which was cultured on Des4 medium. The organism was mutated by UV irradiation hence selective techniques and markers were employed to distinguish marked strains from parent S. griseoflavus .When the mutated organisms were selected according to their characteristics and used to fuse their protoplasts in order to obtain high yield desferrioxamine producing recombinant Streptomyces griseoflavus. The varied parameters were bacterial growth rate and desferal concentration in the culture broth.
Results: Our study showed that the rate of desferal production in mutant's strains called C7031 and S7011 and fusants srains called FP10 and FP9 was higher than wiled type Streptomyces griseoflavus. The increment in production of desferrioxamine was found to be 68% in FP9 and 81% in FP10 fusants. Conclusion: The mutation and protoplasts fusion of Streptomyces griseoflavus caused increment in production of desferrioxamine. The infrared spectrum, thin layer chromatogram of desferrioxamine extracted from culture broth was similar to that of standard desferrioxamine (Novartis) from the point of molecular identity.
Keywords: Streptomyces griseoflavus, Mutant, Protoplast fusion, Desferal production.
Full-Text [PDF 549 kb]   (5118 Downloads)    
Subject: Epidemiology
Received: 2006/09/6 | Published: 2006/12/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbarzadeh A, Noruzian D, Farhangi A, Mehrabi M, Atyabi S, Zare D, et al . Surveying Desferal production increment by inducing mutation in Streptomyces griseoflavus. MEDICAL SCIENCES 2006; 16 (4) :225-230
URL: http://tmuj.iautmu.ac.ir/article-1-105-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 4 (Winter 2006) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.07 seconds with 37 queries by YEKTAWEB 4645